Pre and Probiotics In Paediatrics
DOI:
https://doi.org/10.46858/vimshsj.10208Keywords:
Probiotics, Prebiotics, Synbiotic, Postbiotic, Functional foodAbstract
Microbes are all around us and play a significant role in both our overall health and the health of the planet. The interest in adding probiotics and prebiotics to nutritional goods has developed as a result of efforts to improve the internal microbial environment. Probiotic and prebiotic use and effectiveness should be supported by evidence-based medicine, just like with antibiotics. This clinical report's goal is to evaluate the medical applications of probiotics and prebiotics and to provide a summary of what is currently known regarding the health advantages of including them as dietary supplements in foods marketed to children, such as infant formula. The guidance in this report will help paediatric health care providers to make appropriate decisions regarding the usefulness and benefit of probiotics and prebiotics for their patients.
Downloads
References
Food and Agriculture Organization of the United Nations; World Health Organization. Guidelines for the evaluation of probiotics in food: joint FAO/WHO Working Group re- port on drafting guidelines for the evalua- tion of probiotics in food. Available at: ftp://ftp.fao.org/es/esn/food/wgreport2. pdf. Accessed October 1, 2010.
Food and Agriculture Organization of the United Nations; World Health Organization. Health and nutritional properties of probi- otics in food including powder milk with live lactic acid bacteria: report of a joint FAO/WHO expert consultation on evalua- tion of health and nutritional properties of probiotics in food including powder milk with live lactic acid bacteria. Available at: www.who.int/foodsafety/publications/fs_ management/en/probiotics.pdf. Accessed October 1, 2010.
Council for Agricultural Science and Tech- nology. Probiotics: Their Potential to Im- pact Human Health. Ames, IA: Council for Agricultural Science and Technology; 2007. Available at: www.cast-science. org/websiteUploads/publicationPDFs/ CAST%20Probiotics%20Issue%20Paper% 20FINAL144.
Roberfroid M. Prebiotics: the concept revisited. J Nutr. 2007;137(3 suppl 2): 830S– 837S.
Commane DM, Shortt CT, Silvi S, Cresci A, Hughes RM, Rowland IR. Effects of fermen- tation products of pro- and prebiotics on trans-epithelial electrical resistance in an in vitro model of the colon. Nutr Cancer. 2005;51(1):102–109.
Falony G, Vlachou A, Verbrugghe K, De Vuyst L. Cross-feeding between Bifidobac- terium longum BB536 and acetate- converting, butyrate-producing colon bac- teria during growth on oligofructose. Appl Environ Microbiol. 2006;72(12):7835–7841.
Grönlund MM, Gueimonde M, Laitinen K, et al. Maternal breast-milk and intestinal bi- fidobacteria guide the compositional de- velopment of the Bifidobacterium micro- biota in infants at risk of allergic disease. Clin Exp Allergy. 2007;37(12):1764 –1772.
Kullen MJ, Bettler J. The delivery of probi- otics and prebiotics to infants. Curr Pharm Des. 2005;11(1):55–74.
Michail S, Sylvester F, Fuchs G, Issenman R. Clinical efficacy of probiotics: review of the evidence with focus on children. J Pe- diatr Gastroenterol Nutr. 2006;43(4): 550 –557.
BoyleRJ,Robins-BrowneRM,TangML.Pro- biotic use in clinical practice: what are the risks? Am J Clin Nutr. 2006;83(6): 1256 –1264; quiz 1446 –1257.
Szajewska H, Setty M, Mrukowicz J, Guan- dalini S. Probiotics in gastrointestinal dis- eases in children: hard and not-so-hard ev- idence of efficacy. J Pediatr Gastroenterol Nutr. 2006;42(5):454 – 475.
Agostoni C, Axelsson I, Braegger C, et al. Probiotic bacteria in dietetic products for infants: a commentary by the ESPGHAN Committee on Nutrition. J Pediatr Gastro- enterol Nutr. 2004;38(4):365–374.
Saavedra JM. Clinical applications of pro- biotic agents. Am J Clin Nutr. 2001;73(6): 1147S–1151S.
Matarese LE, Seidner DL, Steiger E. The role of probiotics in gastrointestinal dis- ease. Nutr Clin Pract. 2003;18(6):507–516.
Björkstén B, Naaber P, Sepp E, Mikelsaar M. The intestinal microflora in allergic Es- tonian and Swedish 2-year-old children. Clin Exp Allergy. 1999;29(3):342–346.
Heller F, Duchmann R. Intestinal flora and mucosal immune responses. Int J Med Mi- crobiol. 2003;293(1):77– 86.
Berg RD. Bacterial translocation from the gastrointestinal tract. Adv Exp Med Biol. 1999;473:11–30.
QuanR,BarnessLA.Doinfantsneednucle- otide supplemented formula for optimal nutrition? J Pediatr Gastroenterol Nutr. 1990;11(4):429 – 434.
Boehm G, Stahl B. Oligosaccharides from milk. J Nutr. 2007;137(3 suppl 2): 847S– 849S.
Oberhelman RA, Gilman RH, Sheen P, et al. A placebo-controlled trial of Lactobacillus GG to prevent diarrhea in undernourished Peruvian children. J Pediatr. 1999;134(1): 15–20.
Hatakka K, Savilahti E, Ponka A, et al. Effect of long term consumption of probiotic milk on infections in children attending day care centres: double blind, random- ised trial. BMJ. 2001;322(7298):1327.
Thibault H, Aubert-Jacquin C, Goulet O. Ef- fects of long-term consumption of a fer- mented infant formula (with Bifidobacte- rium breve c50 and Streptococcus thermophilus 065) on acute diarrhea in healthy infants. J Pediatr Gastroenterol Nutr. 2004;39(2):147–152.
Saavedra JM, Abi-Hanna A, Moore N, Yolken RH. Long-term consumption of in- fant formulas containing live probiotic bacteria: tolerance and safety. Am J Clin Nutr. 2004;79(2):261–267.
Szyman ? ski H, Pejcz J, Jawien ? M, Chmielarc- zyk A, Strus M, Heczko PB. Treatment of acute infectious diarrhoea in infants and children with a mixture of three Lactoba- cillus rhamnosus strains: a randomized, double-blind, placebo-controlled trial. Ali- ment Pharmacol Ther. 2006;23(2):247–253.
Szajewska H, Mrukowicz JZ. Probiotics in the treatment and prevention of acute in- fectious diarrhea in infants and children: a systematic review of published random- ized, double-blind, placebo-controlled tri- als. J Pediatr Gastroenterol Nutr. 2001; 33(suppl 2):S17–S25.
Van Niel CW, Feudtner C, Garrison MM, Christakis DA. Lactobacillus therapy for acute infectious diarrhea in children: a meta-analysis. Pediatrics. 2002;109(4): 678 – 684.
Huang JS, Bousvaros A, Lee JW, Diaz A, Da- vidson EJ. Efficacy of probiotic use in acute diarrhea in children: a meta-analysis. Dig Dis Sci. 2002;47(11):2625–2634.
Allen SJ, Okoko B, Martinez E, Gregorio G, Dans LF. Probiotics for treating infectious diarrhoea. Cochrane Database Syst Rev. 2004;(2):CD003048.
Cukrowska, B. Microbial and nutritional programming—The importance of the microbiome and early exposure to potential food allergens in the development of allergies. Nutrients 2018, 10, 1541.
Díaz, M.; Guadamuro, L.; Espinosa-Martos, I.; Mancabelli, L.; Jiménez, S.; Molinos-Norniella, C.; Pérez-Solis, D.; Milani, C.; Rodríguez, J.M.; Ventura, M.; et al. Microbiota and derived parameters in fecal samples of infants with non-IgE cow’s milk protein allergy under a restricted diet. Nutrients 2018, 10, 1481.
Huang, C.F.; Chie, W.C.; Wang, I.J. Efficacy of Lactobacillus administration in school-age children with asthma: A randomized, placebo-controlled trial. Nutrients 2018, 10, 1678.
Szajewska, H.; Horvath, A. Lactobacillus rhamnosus GG in the primary prevention of eczema in children: Asystematic review and meta-analysis. Nutrients 2018, 10, 1319.
Vandenplas, Y.; Abkari, A.; Bellaiche, M.; Benninga, M.; Chouraqui, J.P.; Çokura, F.; Harb, T.; Hegar, B.; Lifschitz, C.; Ludwig, T.; et al. Prevalence and health outcomes of functional gastrointestinal symptoms in infants from birth to 12 months of age. J. Pediatr. Gastroenterol. Nutr. 2015, 61, 531–537.
Savino, F.; Tarasco, V. New treatments for infant colic. Curr. Opin. Pediatr. 2010, 22, 791–797.
Gerasimov, S.; Gantzel, J.; Dementieva, N.; Schevchenko, O.; Tsitsura, O.; Guta, N.; Bobyk, V.; Kaprus, V. Role of Lactobacillus rhamnosus (FloraActive™) 19070-2 and Lactobacillus reuteri (FloraActive™) 12246 in infant colic: A randomized dietary study. Nutrients 2018, 10, 1975.
Baldassarre, M.E.; Di Mauro, A.; Tafuri, S.; Rizzo, V.; Gallone, M.S.; Mastromarino, P.; Capobianco, D.; Laghi, L.; Zhu, C.; Capozza, M.; et al. Effectiveness and safety of a probiotic-mixture for the treatment of infantile colic: A double-blind, randomized, placebo-controlled clinical trial with fecal real-time PCR and NMR-based metabolomics analysis. Nutrients 2018, 10, 195.
Pärtty, A.; Rautava, S.; Kalliomäki, M. Probiotics on pediatric functional gastrointestinal disorders. Nutrients 2018, 10, 1836.
Aceti, A.; Beghetti, I.; Maggio, L.; Martini, S.; Faldella, G.; Corvaglia, L. Filling the Gaps: Current Research Directions for a Rational Use of Probiotics in Preterm Infants. Nutrients 2018, 10, 1472.
Aceti, A.; Maggio, L.; Beghetti, I.; Gori, D.; Barone, G.; Callegari, M.L.; Fantini, M.P.; Indrio, F.; Meneghin, F.; Italian Society of Neonatology; et al. Probiotics prevent late-onset sepsis in human milk-fed, very low birth weight preterm infants: Systematic review and meta-analysis. Nutrients 2017, 9, 904.
VandenAkker, C.H.P.; van Goudoever, J.B.; Szajewska, H.; Embleton, N.D.; Hojsak, I.; Reid, D.; Shamir, R.; ESPGHANWorkingGroupfor Probiotics, Prebiotics & Committee on Nutrition; et al. Probiotics for preterm infants: A strain-specific systematic review and network meta-analysis. J. Pediatr. Gastroenterol. Nutr. 2018, 67, 103–122.
Vandenplas, Y.; Berger, B.; Carnielli, V.P.; Ksiazyk, J.; Lagström, H.; Sanchez Luna, M.; Migacheva, N.; Mosselmans, J.M.; Picaud, J.C.; Possner, M.; et al. Human milk oligosaccharides: 2-Fucosyllactose (2-FL) and Lacto-N-Neotetraose (LNnT) in infant formula. Nutrients 2018, 10, 1161.
Triantis, V.; Bode, L.; van Neerven, R.J.J. Immunological effects of human milk oligosaccharides. Front. Pediatr. 2018, 6, 190.
Bering,S.B. Humanmilkoligosaccharides toprevent gut dysfunction and necrotizing enterocolitis in preterm neonates. Nutrients 2018, 10, 1461.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Dr. Hamza Solkar, Dr. Suresh Waydande, Dr. Abhijit Shinde, Prof. Dr. Sunil Natha Mhaske, Dr. Sonal Shinde Nikam
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
